Table 1 Counts of trials by phase, publications and sponsors aggregated by intervention
From: regCOVID: Tracking publications of registered COVID-19 studies
Intervention | Trial count | Intervention significance score | Number of sponsors | Number of publications |
|---|---|---|---|---|
Hydroxychloroquine | 122 | 11.122 | 102 | 86 |
Ivermectin | 46 | 11.046 | 42 | 14 |
Remdesivir | 46 | 11.046 | 31 | 28 |
Azithromycin | 43 | 11.043 | 40 | 35 |
Tocilizumab | 41 | 11.041 | 37 | 26 |
Ritonavir | 33 | 11.033 | 25 | 25 |
Vitamin D | 26 | 11.026 | 23 | 7 |
Colchicine | 24 | 11.024 | 24 | 17 |
mrna-1273 | 15 | 10.015 | 7 | 12 |
bnt162b2 | 16 | 9.016 | 7 | 11 |